- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Exploring the Current State of Precision Medicine at the ASCO Annual Meeting
During this year's American Society of Clinical Oncology (ASCO) annual meeting, we sat down with 4 physicians to discuss their experiences with precision medicine, how it's changing oncology care, challenges associated with the shift, and where they think the future of precision medicine is headed.
As precision medicine continues to play a growing role in oncology, this year's American Society of Clinical Oncology (ASCO) annual meeting drew in more than 30,000 oncology professionals to discuss new research and practices surrounding the movement. While precision medicine comes with great promise for patient outcomes, it also comes with new and complex challenges for physicians.
During the ASCO annual meeting, we sat down with 4 physicians to discuss their experiences with precision medicine, how it's changing oncology care, challenges associated with the shift, and where they think the future of precision medicine is headed.
To listen, login to the website.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss?rel=0" ?rel=0"
TuneIn: http://bit.ly/2gv7iwj?rel=0"
Stitcher: http://bit.ly/2gCqtFg?rel=0"
Read more:
Oncologists Are Crucial to Advancing Precision Medicine
Implementing an Oncology Precision Medicine Clinic in a Large Community Health System
Recognizing the Value of Precision Medicine: Oncology and Beyond
Syapse, Roche Team Up to Advance Precision Medicine in Oncology
Dr Leonard B. Saltz: The Role of Next-Generation Sequencing in Advancing Precision Medicine
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
